ZIM Laboratories Limited (BSE: 541400)
Health Care · Pharmaceuticals · IN
Rs150.70
+10.44% today · +110.0% 1Y
ZIM Laboratories Limited (BSE: 541400) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $83.55M.
Over the last twelve months the share price has gained 110.0%, trading between 59.72 and 154.00.
Tweenvest scores ZIM Laboratories Limited across four factors: quality 66/100, value 32/100, growth 19/100. Its strongest factor is quality.
541400 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $83.55M
- Revenue (TTM)
- $41.97M
- P/E
- 204.53
- EPS
- 0.74
- Dividend yield
- —
- Beta (5Y)
- 0.82
- 52-week high
- Rs154.00
- 52-week low
- Rs59.72
- Avg volume (3M)
- —
- Shares outstanding
- 53.66M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chunghwa Chemical Synthesis & Biotech Co., Ltd.TWSE: 1762 | $85.04M | NT$35.35 | +4.74% |
| Protect Animal Health Inc.TPEX: 7850 | $84.75M | NT$27.75 | +13.96% |
| Anuh Pharma LimitedBSE: 506260 | $84.47M | Rs81.57 | -6.11% |
| Vistin Pharma ASAOB: VISTN | $83.90M | Nkr18.00 | -0.55% |
| Cognition Therapeutics, Inc.NasdaqCM: CGTX | $83.39M | $0.86 | -2.28% |
| Rafael Holdings, Inc.NYSE: RFL | $83.20M | $1.50 | -6.25% |
| HANDOK Inc.KOSE: A002390 | $83.10M | ₩8,600.00 | +0.47% |
| Nyrada Inc.ASX: NYR | $82.93M | AU$0.48 | -7.69% |
Figures last refreshed Oct 11, 2026.